Related Experiment Video
Updated: Jun 19, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Intravenous immunoglobulins--understanding properties and mechanisms
A Durandy1, S V Kaveri, T W Kuijpers
1INSERM U768, Université Paris-Descartes, Hospital Necker, Paris, France.
High-dose intravenous immunoglobulin (IVIg) has anti-inflammatory effects in autoimmune diseases, but its exact mechanism remains unclear. Research explores how IVIg impacts immune cells, complement, and specific IgG components to understand its therapeutic action.
Area of Science:
- Immunology
- Pharmacology
- Autoimmune disease research
Background:
- High-dose intravenous immunoglobulin (IVIg) is used for autoimmune and inflammatory diseases.
- The precise mechanism of IVIg's anti-inflammatory action at high concentrations is not fully understood.
- IVIg can exhibit both pro- and anti-inflammatory effects depending on concentration.
Purpose of the Study:
- To elucidate the mechanisms underlying the anti-inflammatory properties of high-dose IVIg.
- To explore various proposed pathways, including cellular effects, complement scavenging, and IgG molecular composition.
Main Methods:
- Review of presentations from the 6th International Immunoglobulin Symposium.
- Discussion of IgG's effects on cellular compartments.
- Examination of complement fragment scavenging by IVIg.
- Analysis of the role of dimeric and sialylated IgG fractions.
- Consideration of Fcgamma receptor (FcgammaR) genetics.
Main Results:
- Progress has been made in understanding IVIg's mechanisms of action.
- Evidence suggests IVIg affects cellular compartments and scavenges complement fragments.
- The role of specific IgG fractions (dimeric, sialylated) and FcgammaR variations are being investigated.
Conclusions:
- Understanding IVIg mechanisms is advancing significantly.
- These insights may shape future immunoglobulin (Ig) therapy strategies.
- Further research into IVIg's complex interactions is crucial for optimizing treatment.
More Related Videos
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Inhibitors of Viral Protein Synthesis

